Quantitative Systematic Strategies’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Quantitative Systematic Strategies’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,031	Closed	-$287K	–	411
2021 Q2	$287K	Sell	2,031 -3,329	-62%	-$376K	0.1%	339
2021 Q1	$534K	Sell	5,360 -660	-11%	-$77K	0.08%	360
2020 Q4	$744K	Buy	6,020 +1,235	+26%	+$162K	0.11%	302
2020 Q3	$466K	Buy	4,785 +2,853	+148%	+$356K	0.08%	342
2020 Q2	$301K	Buy	+1,932	New	+$294K	0.06%	417
2020 Q1	–	Sell	-2,866	Closed	-$586K	–	582
2019 Q4	$586K	Buy	+2,866	New	+$523K	0.09%	302

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Quantitative Systematic Strategies's RETA Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2021, closing a stake of 2,031 shares — an estimated $287K sold.

Quantitative Systematic Strategies first reported a position in RETA in Q4 2019 and held it in 6 quarters. The position peaked at $744K in Q4 2020. 181 funds tracked by Wall St. Rank hold RETA as of Q3 2021.

Quantitative Systematic Strategies reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 2,031 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2021, an estimated $287K.
Quantitative Systematic Strategies first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 6 quarters.
Quantitative Systematic Strategies's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $744K in Q4 2020.
181 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.